Glycosylation in Stem Cell Biology.

Q1 Pharmacology, Toxicology and Pharmaceutics
Chika Ogura, Shoko Nishihara
{"title":"Glycosylation in Stem Cell Biology.","authors":"Chika Ogura, Shoko Nishihara","doi":"10.1007/164_2025_748","DOIUrl":null,"url":null,"abstract":"<p><p>Embryonic stem cells are pluripotent stem cells originally derived from the inner cell mass of blastocysts and have the essential characteristics of pluripotency and self-renewal. Pluripotent stem cells can differentiate into all of the cell types constituting the adult body. Our current understanding is that pluripotent stem cells transition through three stages: a naïve state, a formative state, and a primed state. The stemness and differentiation of pluripotent stem cells depend on cell-surface glycans, which work as essential modulators in ligand-receptor interactions, cell-cell interactions, and cell-extracellular matrix interactions. Cell-surface glycans bind to various signal ligands, including Wnt, fibroblast growth factors, and bone morphogenetic proteins, and are tissue-specific and developmentally regulated. In addition, intracellular O-linked N-acetylglucosamine, a modification found on only nuclear or cytoplasmic proteins, regulates core transcription factors involved in stemness, phosphorylation of downstream signal components, epigenetics, and liquid-liquid phase separation. Thus, various kinds of glycans regulate each stem cell status; furthermore, different glycan structures at each stage are simultaneously epigenetically regulated by the polycomb repressive complex PRC2. Understanding the functions of glycans in stemness and differentiation is increasingly important for both innovative clinical applications and basic research. This chapter focuses on the roles of glycans in mouse and human pluripotent stem cells.</p>","PeriodicalId":12859,"journal":{"name":"Handbook of experimental pharmacology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Handbook of experimental pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/164_2025_748","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Embryonic stem cells are pluripotent stem cells originally derived from the inner cell mass of blastocysts and have the essential characteristics of pluripotency and self-renewal. Pluripotent stem cells can differentiate into all of the cell types constituting the adult body. Our current understanding is that pluripotent stem cells transition through three stages: a naïve state, a formative state, and a primed state. The stemness and differentiation of pluripotent stem cells depend on cell-surface glycans, which work as essential modulators in ligand-receptor interactions, cell-cell interactions, and cell-extracellular matrix interactions. Cell-surface glycans bind to various signal ligands, including Wnt, fibroblast growth factors, and bone morphogenetic proteins, and are tissue-specific and developmentally regulated. In addition, intracellular O-linked N-acetylglucosamine, a modification found on only nuclear or cytoplasmic proteins, regulates core transcription factors involved in stemness, phosphorylation of downstream signal components, epigenetics, and liquid-liquid phase separation. Thus, various kinds of glycans regulate each stem cell status; furthermore, different glycan structures at each stage are simultaneously epigenetically regulated by the polycomb repressive complex PRC2. Understanding the functions of glycans in stemness and differentiation is increasingly important for both innovative clinical applications and basic research. This chapter focuses on the roles of glycans in mouse and human pluripotent stem cells.

干细胞生物学中的糖基化。
胚胎干细胞是起源于囊胚内部细胞群的多能干细胞,具有多能性和自我更新的本质特征。多能干细胞可以分化成构成成体的所有细胞类型。我们目前的理解是,多能干细胞通过三个阶段转变:naïve状态,形成状态和启动状态。多能干细胞的干性和分化依赖于细胞表面聚糖,它在配体-受体相互作用、细胞-细胞相互作用和细胞-细胞外基质相互作用中起重要的调节作用。细胞表面聚糖结合多种信号配体,包括Wnt、成纤维细胞生长因子和骨形态发生蛋白,具有组织特异性和发育调控。此外,细胞内O-linked N-acetylglucosamine是一种仅存在于细胞核或细胞质蛋白上的修饰物,它可以调节涉及干性、下游信号组分磷酸化、表观遗传学和液-液相分离的核心转录因子。因此,各种聚糖调节着干细胞的各种状态;此外,每个阶段的不同聚糖结构同时受到多梳抑制复合体PRC2的表观遗传调控。了解聚糖在干细胞和分化中的功能对创新临床应用和基础研究越来越重要。本章主要讨论多糖在小鼠和人多能干细胞中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Handbook of experimental pharmacology
Handbook of experimental pharmacology Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
5.20
自引率
0.00%
发文量
54
期刊介绍: The Handbook of Experimental Pharmacology is one of the most authoritative and influential book series in pharmacology. It provides critical and comprehensive discussions of the most significant areas of pharmacological research, written by leading international authorities. Each volume in the series represents the most informative and contemporary account of its subject available, making it an unrivalled reference source.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信